These procedures, like the overall diagnostic process, do not differ significantly between eFAD and LOAD. None of them constitutes a stand-alone diagnostic. At the end of the day, AD is a disease of ...

These various tests are at different stages of validation – assuring they’re accurate across many different populations. And, for each protein, there are several different met ...

Huntington's has a longer history of genetic testing than does AD. It poses similar challenges to AD and therefore ... individual is a candidate for predictive testing, to explain the procedure, and ...

Beyond drug discovery, Eisai is committed to developing the appropriate infrastructure for AD treatment, including blood biomarkers (BBMs) for diagnosis. A new era of AD AD is a progressive ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the potential to transform patient care, allowing for better diagnosis, earlier ...